3 Comments
User's avatar
Dr Mark Chern's avatar

Thank you for this article, Hussein! I keep thinking about how anti-amyloid antibodies might actually be exhausting already-compromised microglia in APOE4 carriers rather than rescuing them. The timing question feels underappreciated in the clinical conversation.

Hussein Yassine's avatar

It is a good question. These treatments trigger microglia to phagocytose and clear abeta. Whether they induce a state of exhaustion is not known. However, tiggering this pathway in blood vessels with abeta provides an explanation for the side effect ARIA, where the blood vessel becomes inflamed with immune cells trying to clear amyloid.